Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,894 | 436 | 93.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $383.84 | 19 | 6.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $618.76 | 66 | $0 (2020) |
| Avanir Pharmaceuticals, Inc. | $542.51 | 70 | $0 (2019) |
| GENZYME CORPORATION | $500.23 | 28 | $0 (2020) |
| EMD Serono, Inc. | $495.10 | 32 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $447.40 | 33 | $0 (2020) |
| Acorda Therapeutics, Inc | $383.84 | 19 | $0 (2019) |
| UCB, Inc. | $290.17 | 19 | $0 (2020) |
| Allergan, Inc. | $283.99 | 22 | $0 (2020) |
| Grifols USA, LLC | $253.84 | 18 | $0 (2018) |
| ACADIA Pharmaceuticals Inc | $232.92 | 15 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $28.20 | 2 | HOSPIRA, INC. ($28.20) |
| 2022 | $70.16 | 5 | Biohaven Pharmaceutical Holding Company Ltd. ($30.59) |
| 2021 | $17.12 | 1 | Alexion Pharmaceuticals, Inc. ($17.12) |
| 2020 | $966.90 | 54 | GENZYME CORPORATION ($107.86) |
| 2019 | $1,692 | 139 | Avanir Pharmaceuticals, Inc. ($253.43) |
| 2018 | $1,804 | 135 | Biogen, Inc. ($184.54) |
| 2017 | $1,699 | 119 | Biogen, Inc. ($167.55) |
All Payment Transactions
455 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/28/2024 | HOSPIRA, INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: IMMUNOLOGY | ||||||
| 04/26/2024 | HOSPIRA, INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: IMMUNOLOGY | ||||||
| 09/14/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: PRIMARY CARE | ||||||
| 08/23/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: PRIMARY CARE | ||||||
| 05/12/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Central Nervous System | ||||||
| 03/24/2022 | Janssen Pharmaceuticals, Inc | Ponvory (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Neuroscience | ||||||
| 02/18/2022 | Janssen Pharmaceuticals, Inc | Ponvory (Drug) | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: Neuroscience | ||||||
| 02/12/2021 | Alexion Pharmaceuticals, Inc. | Soliris (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Immunology | ||||||
| 12/21/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: HYPERHYDROSIS | ||||||
| 12/16/2020 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: NEUROLOGY | ||||||
| 12/14/2020 | Eisai Inc. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $20.26 | General |
| Category: Neurology | ||||||
| 12/11/2020 | AbbVie Inc. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2020 | Neurocrine Biosciences, Inc. | INGREZZA (Drug), ONGENTYS | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: NEUROLOGY | ||||||
| 12/01/2020 | GENZYME CORPORATION | AUBAGIO (Drug), LEMTRADA | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Neurology | ||||||
| 11/20/2020 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: NEUROLOGY | ||||||
| 11/11/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: HYPERHYDROSIS | ||||||
| 11/10/2020 | Eisai Inc. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $20.26 | General |
| Category: Neurology | ||||||
| 11/04/2020 | Neurocrine Biosciences, Inc. | INGREZZA (Drug), ONGENTYS | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: NEUROLOGY | ||||||
| 10/30/2020 | AbbVie Inc. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2020 | GENZYME CORPORATION | LEMTRADA (Biological) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: Neurology | ||||||
| 10/22/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: HYPERHYDROSIS | ||||||
| 10/09/2020 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/05/2020 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Neurology | ||||||
| 09/29/2020 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: Central Nervous System | ||||||
| 09/23/2020 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 261 | 553 | $288,029 | $70,796 |
| 2022 | 7 | 289 | 513 | $223,117 | $62,086 |
| 2021 | 6 | 191 | 401 | $207,631 | $59,825 |
| 2020 | 8 | 545 | 1,100 | $302,454 | $123,638 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 113 | 293 | $207,690 | $46,514 | 22.4% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 44 | 149 | $53,531 | $11,879 | 22.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 56 | 63 | $12,950 | $6,720 | 51.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 36 | 36 | $11,790 | $4,791 | 40.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 12 | $2,068 | $891.72 | 43.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 106 | 250 | $153,570 | $38,546 | 25.1% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 30 | 98 | $30,645 | $7,778 | 25.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 50 | 52 | $8,984 | $5,050 | 56.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 25 | 25 | $7,654 | $3,211 | 41.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 30 | 39 | $9,555 | $2,905 | 30.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 16 | 16 | $7,600 | $2,304 | 30.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 32 | 33 | $5,109 | $2,292 | 44.9% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 123 | 321 | $185,829 | $53,678 | 28.9% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2021 | 22 | 26 | $7,539 | $2,210 | 29.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 12 | 19 | $4,743 | $1,512 | 31.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 12 | 12 | $2,856 | $1,262 | 44.2% |
| 36556 | Insertion of central venous catheter for infusion, patient 5 years or older, not tunneled | Facility | 2021 | 11 | 12 | $5,376 | $782.04 | 14.5% |
| 36620 | Insertion of arterial catheter for blood sampling or infusion, accessed through the skin | Facility | 2021 | 11 | 11 | $1,288 | $381.15 | 29.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 205 | 581 | $116,200 | $48,988 | 42.2% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 108 | 270 | $117,990 | $48,187 | 40.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 87 | 87 | $33,930 | $14,288 | 42.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 49 | 64 | $8,896 | $3,685 | 41.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 25 | 25 | $6,650 | $2,800 | 42.1% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2020 | 42 | 43 | $7,052 | $2,027 | 28.7% |
| 95720 | Continuous measurement of brain wave activity with video (veeg), 12-26 hours, with health care professional analysis, interpretation and report | Facility | 2020 | 12 | 12 | $7,776 | $2,027 | 26.1% |
About Dr. Kyle Carpenter, DO
Dr. Kyle Carpenter, DO is a Neurology healthcare provider based in Kansas City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2010. The National Provider Identifier (NPI) number assigned to this provider is 1962713081.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kyle Carpenter, DO has received a total of $6,278 in payments from pharmaceutical and medical device companies, with $28.20 received in 2024. These payments were reported across 455 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($5,894).
As a Medicare-enrolled provider, Carpenter has provided services to 1,286 Medicare beneficiaries, totaling 2,567 services with total Medicare billing of $316,345. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Neurocritical Care, Neurology
- Location Kansas City, MO
- Active Since 06/23/2010
- Last Updated 12/05/2016
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1962713081
Products in Payments
- NUEDEXTA (Drug) $341.88
- TYSABRI (Biological) $341.69
- Rebif (Biological) $322.58
- GILENYA (Drug) $300.07
- AUBAGIO (Drug) $275.24
- Gamunex-C (Biological) $253.84
- AMPYRA (Drug) $249.26
- ACTHAR (Biological) $240.25
- NUPLAZID (Drug) $232.92
- TECFIDERA (Drug) $225.72
- Briviact (Drug) $209.86
- BOTOX (Biological) $204.19
- ONZETRA Xsail (Drug) $200.63
- LEMTRADA (Drug) $181.89
- INBRIJA (Drug) $134.58
- Mavenclad (Biological) $129.55
- NORTHERA (Drug) $120.36
- COPAXONE (Drug) $100.31
- AIMOVIG (Biological) $83.50
- Fycompa (Drug) $82.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Kansas City
Ivan Osorio, M.d, M.D
Neurology — Payments: $104.6M
Rajesh Pahwa, M.d, M.D
Neurology — Payments: $1.2M
Stanley Fisher, M.d, M.D
Neurology — Payments: $428,656
Richard Dubinsky, M.d, M.D
Neurology — Payments: $168,037
Dr. Rola Mahmoud, Md, MD
Neurology — Payments: $143,454
Samuel Goldlust, Md, MD
Neurology — Payments: $140,003